Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jörg Ruof

“Market Withdrawals” of Medicines in Germany After AMNOG: A Comparison of HTA Ratings and Clinical Guideline Recommendations

Health Economics Review

English

Leveraging EUnetHTA’s Conceptual Framework to Compare HTA Decision Drivers in France, Italy, and Germany From a Manufacturer’s Point of View

Health Economics Review

English

Related publications

Php31 - Impact of European Medicines Agency (Ema) Clinical Trial Transparency Policies on Health Technology Assessment (Hta) Decisions in Germany

Value in Health

Occupational Health

English

Analysis of Spanish Generic Medicines Market: Recommendations to Enhance Long-Term Sustainability

Value in Health

Occupational Health

English

Increasing Transparency and the Patient Voice in HTA of New Medicines

Value in Health

Occupational Health

English

Php38 - Enzyme Replacement Therapies Within the German Hta (Amnog) Process

Value in Health

Occupational Health

English

Pcn291 - Market Access for Onco-Hematology Medicines : Value of Single Arm Studies - Analysis of French Hta Opinions

Value in Health

Occupational Health

English

Php35 - Amnog Early Benefit Assessment (Eba) and Market Penetration of New Drugs for Melanoma, Multiple Sclerosis and Diabetes Mellitus in Germany

Value in Health

Occupational Health

English

Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline

Hepatitis Monthly

Infectious Diseases

English

Php139 - G-Ba Conditional Approvals in the Amnog Procedure: Impact on Hta Outcomes and Price

Value in Health

Occupational Health

English

Cross-National Comparison of Biosimilar Medicines : Market Penetration and Competition With Originators

Value in Health

Occupational Health

English